47 related articles for article (PubMed ID: 218451)
1. Portacaval shunt and hyperlipidemia.
Starzl TE; Putnam CW; Koep LJ
Arch Surg; 1978 Jan; 113(1):71-4. PubMed ID: 202223
[TBL] [Abstract][Full Text] [Related]
2. Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia.
van Dam M; Zwart M; de Beer F; Smelt AH; Prins MH; Trip MD; Havekes LM; Lansberg PJ; Kastelein JJ
Heart; 2002 Sep; 88(3):234-8. PubMed ID: 12181212
[TBL] [Abstract][Full Text] [Related]
3. Diet and high density lipoproteins.
Oster P; Schlierf G; Heuck CC; Hahn S; Szymanski H; Schellenberg B
Lipids; 1981 Feb; 16(2):93-7. PubMed ID: 7242273
[TBL] [Abstract][Full Text] [Related]
4. [The apolipoproteins in man ].
Schwandt P
Klin Wochenschr; 1982 Jul; 60(13):673-49. PubMed ID: 6750220
[TBL] [Abstract][Full Text] [Related]
5. Pre-beta-very low density lipoproteins as precursors of beta-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia).
Chappell DA
J Clin Invest; 1988 Aug; 82(2):628-39. PubMed ID: 2841358
[TBL] [Abstract][Full Text] [Related]
6. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
Chappell DA
J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
[TBL] [Abstract][Full Text] [Related]
7. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
Patsch JR; Yeshurun D; Jackson RL; Gotto AM
Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188
[No Abstract] [Full Text] [Related]
8. [Familial hyperlipoproteinemia type III].
Patsch JR; Patsch W; Sailer S; Braunsteiner H
Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039
[No Abstract] [Full Text] [Related]
9. Xanthomatosis and hyperlipoproteinemia; a review.
Polano MK
Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
[No Abstract] [Full Text] [Related]
10. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
Weisweiler P; Schwandt P
Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
[TBL] [Abstract][Full Text] [Related]
11. Type IV hyperlipoproteinaemia.
Kwiterovich PO; Margolis S
Clin Endocrinol Metab; 1973 Mar; 2(1):41-71. PubMed ID: 4359117
[No Abstract] [Full Text] [Related]
12. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB
Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
